Referable Macular Hemorrhage-A Clinically Meaningful Screening Target in Newborn Infants. Position Statement of the Association of Pediatric Retina Surgeons.
Ophthalmic Surg Lasers Imaging Retina
; 53(1): 3-6, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-34981999
ABSTRACT
Universal newborn eye screening facilitates early diagnosis of ocular abnormalities and mitigates vision loss. "Referral warranted" eye disease is present at birth in about 5.5% of term infants, with "macular hemorrhage impinging on the fovea" representing about 50% of referral warranted disease. The Association of Pediatric Retina Surgeons held a symposium on February 9, 2021 that culminated in a position statement on "referable macular hemorrhage" (RMH) in newborn infants. RMH is meaningful in that in can cause amblyopia through deprivation, can be readily captured with wide-angle photography in a safe and efficient manner, and may lead to early intervention with mitigation of vision loss. [Ophthalmic Surg Lasers Imaging Retina. 2022;533-6.].
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Eye Diseases
/
Surgeons
Type of study:
Diagnostic_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Child
/
Humans
/
Infant
/
Newborn
Language:
En
Journal:
Ophthalmic Surg Lasers Imaging Retina
Year:
2022
Type:
Article